Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EDOXABAN Cause Haemarthrosis? 55 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Haemarthrosis have been filed in association with EDOXABAN (SAVAYSA). This represents 0.7% of all adverse event reports for EDOXABAN.

55
Reports of Haemarthrosis with EDOXABAN
0.7%
of all EDOXABAN reports
1
Deaths
47
Hospitalizations

How Dangerous Is Haemarthrosis From EDOXABAN?

Of the 55 reports, 1 (1.8%) resulted in death, 47 (85.5%) required hospitalization, and 2 (3.6%) were considered life-threatening.

Is Haemarthrosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EDOXABAN. However, 55 reports have been filed with the FAERS database.

What Other Side Effects Does EDOXABAN Cause?

Anaemia (663) Cerebral infarction (419) Gastrointestinal haemorrhage (378) Renal impairment (359) Cerebrovascular accident (337) Dyspnoea (331) General physical health deterioration (315) Haematuria (312) Fall (298) Cardiac failure (272)

What Other Drugs Cause Haemarthrosis?

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (3,360) EMICIZUMAB-KXWH (487) RIVAROXABAN (429) COAGULATION FACTOR IX RECOMBINANT HUMAN (318) DAMOCTOCOG ALFA PEGOL (299) --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (220) ASPIRIN (208) EFTRENONACOG ALFA (196) COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (190) APIXABAN (169)

Which EDOXABAN Alternatives Have Lower Haemarthrosis Risk?

EDOXABAN vs EDOXABAN TOSILATE EDOXABAN vs EFALIZUMAB EDOXABAN vs EFANESOCTOCOG ALFA EDOXABAN vs EFAVIRENZ EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL

Related Pages

EDOXABAN Full Profile All Haemarthrosis Reports All Drugs Causing Haemarthrosis EDOXABAN Demographics